Optogenetic Medicine: Synthetic Therapeutic Solutions Precision-Guided by Light

Overview

Journal Cold Spring Harb Perspect Med

Specialty General Medicine

Date 2018 Oct 7

PMID 30291146

Citations 19

Authors

Haifeng Ye

Martin Fussenegger

Affiliations

Soon will be listed here.

Abstract

Gene- and cell-based therapies are well recognized as central pillars of next-generation medicine, but controllability remains a critical issue for clinical applications. In this context, optogenetics is opening up exciting new opportunities for precision-guided medicine by using illumination with light of appropriate intensity and wavelength as a trigger signal to achieve pinpoint spatiotemporal control of cellular activities, such as transgene expression. In this review, we highlight recent advances in optogenetics, focusing on devices for biomedical applications. We introduce the construction and applications of optogenetic-based biomedical tools to treat neurological diseases, diabetes, heart diseases, and cancer, as well as bioelectronic implants that combine light-interfaced electronic devices and optogenetic systems into portable personalized precision bioelectronic medical tools. Optogenetics-based technology promises the capability to achieve traceless, remotely controlled precision dosing of an enormous range of therapeutic outputs. Finally, we discuss the prospects for optogenetic medicine, as well as some emerging challenges.

Citing Articles

Recent advances in facilitating the translation of bioelectronic medicine therapies.

Baldwin A, States G, Pikov V, Gunalan P, Elyahoodayan S, Kilgore K Curr Opin Biomed Eng. 2025; 33.

PMID: 39896232 PMC: 11781353. DOI: 10.1016/j.cobme.2024.100575.

Emerging optogenetics technologies in biomedical applications.

Ren H, Cheng Y, Wen G, Wang J, Zhou M Smart Med. 2024; 2(4):e20230026.

PMID: 39188295 PMC: 11235740. DOI: 10.1002/SMMD.20230026.

Reshaping tumor microenvironment by regulating local cytokines expression with a portable smart blue-light controlled device.

Wang H, Zhang Y, Mo Y, Zhang Z, Chen R, Lu X Commun Biol. 2024; 7(1):916.

PMID: 39080467 PMC: 11289142. DOI: 10.1038/s42003-024-06566-y.

Optogenetic therapeutic strategies for diabetes mellitus.

Deng X, Peng D, Yao Y, Huang K, Wang J, Ma Z J Diabetes. 2024; 16(6):e13557.

PMID: 38751366 PMC: 11096815. DOI: 10.1111/1753-0407.13557.

Recent Advancements in Bioelectronic Medicine: A Review.

Das S, Ghosh B, Sahoo R, Nayak A Curr Drug Deliv. 2024; 21(11):1445-1459.

PMID: 38173212 DOI: 10.2174/0115672018286832231218112557.

References

Klapoetke N, Murata Y, Kim S, Pulver S, Birdsey-Benson A, Cho Y . Independent optical excitation of distinct neural populations. Nat Methods. 2014; 11(3):338-46. PMC: 3943671. DOI: 10.1038/nmeth.2836. View

Malone J . Greek nurses reach crisis point. Nurs Stand. 2012; 26(37):18-9. View

Casanova E, Fehsenfeld S, Lemberger T, Shimshek D, Sprengel R, Mantamadiotis T . ER-based double iCre fusion protein allows partial recombination in forebrain. Genesis. 2002; 34(3):208-14. DOI: 10.1002/gene.10153. View

Han X, Boyden E . Multiple-color optical activation, silencing, and desynchronization of neural activity, with single-spike temporal resolution. PLoS One. 2007; 2(3):e299. PMC: 1808431. DOI: 10.1371/journal.pone.0000299. View

Bruegmann T, Malan D, Hesse M, Beiert T, Fuegemann C, Fleischmann B . Optogenetic control of heart muscle in vitro and in vivo. Nat Methods. 2010; 7(11):897-900. DOI: 10.1038/nmeth.1512. View

Ye H, Xie M, Xue S, Hamri G, Yin J, Zulewski H . Self-adjusting synthetic gene circuit for correcting insulin resistance. Nat Biomed Eng. 2017; 1(1):0005. PMC: 5412959. DOI: 10.1038/s41551-016-0005. View

Shao J, Wang M, Yu G, Zhu S, Yu Y, Heng B . Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation. Proc Natl Acad Sci U S A. 2018; 115(29):E6722-E6730. PMC: 6055150. DOI: 10.1073/pnas.1802448115. View

Pattanayak V, Lin S, Guilinger J, Ma E, Doudna J, Liu D . High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol. 2013; 31(9):839-43. PMC: 3782611. DOI: 10.1038/nbt.2673. View

Kellendonk C, Tronche F, Monaghan A, Angrand P, Stewart F, Schutz G . Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res. 1996; 24(8):1404-11. PMC: 145830. DOI: 10.1093/nar/24.8.1404. View

10.

Mercy G, Mozziconacci J, Scolari V, Yang K, Zhao G, Thierry A . 3D organization of synthetic and scrambled chromosomes. Science. 2017; 355(6329). PMC: 5679085. DOI: 10.1126/science.aaf4597. View

11.

Folcher M, Oesterle S, Zwicky K, Thekkottil T, Heymoz J, Hohmann M . Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant. Nat Commun. 2014; 5:5392. PMC: 4241983. DOI: 10.1038/ncomms6392. View

12.

Perez-Pinera P, Kocak D, Vockley C, Adler A, Kabadi A, Polstein L . RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods. 2013; 10(10):973-6. PMC: 3911785. DOI: 10.1038/nmeth.2600. View

13.

Maeder M, Linder S, Cascio V, Fu Y, Ho Q, Joung J . CRISPR RNA-guided activation of endogenous human genes. Nat Methods. 2013; 10(10):977-9. PMC: 3794058. DOI: 10.1038/nmeth.2598. View

14.

Weitzman M, Hahn K . Optogenetic approaches to cell migration and beyond. Curr Opin Cell Biol. 2014; 30:112-20. PMC: 4215803. DOI: 10.1016/j.ceb.2014.08.004. View

15.

Laplante M, Sabatini D . mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93. PMC: 3331679. DOI: 10.1016/j.cell.2012.03.017. View

16.

Favory J, Stec A, Gruber H, Rizzini L, Oravecz A, Funk M . Interaction of COP1 and UVR8 regulates UV-B-induced photomorphogenesis and stress acclimation in Arabidopsis. EMBO J. 2009; 28(5):591-601. PMC: 2657586. DOI: 10.1038/emboj.2009.4. View

17.

Ledochowitsch P, Yazdan-Shahmorad A, Bouchard K, Diaz-Botia C, Hanson T, He J . Strategies for optical control and simultaneous electrical readout of extended cortical circuits. J Neurosci Methods. 2015; 256:220-31. PMC: 6284522. DOI: 10.1016/j.jneumeth.2015.07.028. View

18.

Deisseroth K, Feng G, Majewska A, Miesenbock G, Ting A, Schnitzer M . Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci. 2006; 26(41):10380-6. PMC: 2820367. DOI: 10.1523/JNEUROSCI.3863-06.2006. View

19.

Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren J . Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006; 203(10):2315-27. PMC: 2118112. DOI: 10.1084/jem.20061469. View

20.

Grundy S . Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov. 2006; 5(4):295-309. DOI: 10.1038/nrd2005. View